Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a Locations section with Brussels Capital and Namur as study sites, replacing the prior Brussels Capital Locations and Namur Locations entries. Footer updates remove the HHS Vulnerability Disclosure and the page revision is updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-22T22:32:41.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing the previous v3.3.1. This appears to be a minor system update with no changes to the study details or functionality.
    Difference
    0.0%
    Check dated 2025-12-01T12:49:08.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill notice in Publications and updated the Revision to v3.3.1; the previous PubMed wording and Revision: v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T10:57:05.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The funding-status notice banner about government funding lapse has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T06:03:28.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The updates shown in the screenshots are limited to the last update timestamp and minor text edits. There are no changes to the primary study information, such as design, endpoints, eligibility criteria, or participating sites.
    Difference
    0.4%
    Check dated 2025-11-03T00:41:20.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T06:25:36.000Z thumbnail image

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.